Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial

S, Jessan; S, Saleem; MK, Hoffman; SS, Goudar; RJ, Derman; JL, Moore; A, Garces; L, Figueroa; NF, Krebs; J, Okitawutshu; A, Tshefu; CL, Bose; M, Mwenechanya; E, Chomba; WA, Carlo; PK, Das; A, Patel; PL, Hibberd; F, Esamai; EA, Liechty; S, Bucher; TL, Nolen; M, Koso-Thomas; M, Miodovnik; EM, McClure; RL, Goldenberg

dc.contributor.author	S, Jessan
dc.contributor.author	S, Saleem
dc.contributor.author	MK, Hoffman
dc.contributor.author	SS, Goudar
dc.contributor.author	RJ, Derman
dc.contributor.author	JL, Moore
dc.contributor.author	A, Garces
dc.contributor.author	L, Figueroa
dc.contributor.author	NF, Krebs
dc.contributor.author	J, Okitawutshu
dc.contributor.author	A, Tshefu
dc.contributor.author	CL, Bose
dc.contributor.author	M, Mwenechanya
dc.contributor.author	E, Chomba
dc.contributor.author	WA, Carlo
dc.contributor.author	PK, Das
dc.contributor.author	A, Patel
dc.contributor.author	PL, Hibberd
dc.contributor.author	F, Esamai
dc.contributor.author	EA, Liechty
dc.contributor.author	S, Bucher
dc.contributor.author	TL, Nolen
dc.contributor.author	M, Koso-Thomas
dc.contributor.author	M, Miodovnik
dc.contributor.author	EM, McClure
dc.contributor.author	RL, Goldenberg
dc.date.accessioned	2023-02-06T11:12:05Z
dc.date.available	2023-02-06T11:12:05Z
dc.date.issued	2021-04-12
dc.identifier.uri	http://41.89.205.12/handle/123456789/1823
dc.description.abstract	Limited data are available from low- and middleincome countries (LMICs) on the relationship of haemoglobin levels to adverse outcomes at different times during pregnancy. We evaluated the association of haemoglobin levels in nulliparous women at two times in pregnancy with pregnancy outcomes	en_US
dc.description.sponsorship	ALUPE UNIVERSITY	en_US
dc.language.iso	en	en_US
dc.publisher	John Wiley & Sons Ltd.	en_US
dc.subject	Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial	en_US
dc.title	Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial	en_US
dc.title.alternative	Association of haemoglobin levels in the first trimester and at 26–30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women’s and Children’s Health’s ASPIRIN Trial	en_US
dc.type	Other	en_US